The main pharmacological interventions for palliation of breathlessness would be opioids, ie, oromorph and benzodiazepines ...

Mesothelioma is a rare but almost always fatal form of cancer linked to asbestos exposure. It is predominantly detected among ...

Eastwood MSP Jackson Carlaw highlighted a concerning pattern of mesothelioma deaths in East Renfrewshire. Mr Carlaw highlighted the issue during an Action Mesothelioma Day debate at Holyrood, sharing ...

Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural ...

By the 1970s, over 1,400 million pounds of asbestos were used annually in America. A large portion of this material was ...

Asbestos can’t be removed from the lungs after exposure, and there are no treatments. After exposure, people are recommended ...

The malignant pleural mesothelioma market is poised for steady growth during the forecast period (2025–2034). The launch of innovative therapies by companies such as AstraZeneca, Polaris ...

Pleural mesothelioma, specifically, is the most common type of mesothelioma, and it affects the mesothelial lining around the lungs. Why Are the Symptoms of Pleural Mesothelioma So Hard to Spot?

59 Reliable discrimination between benign reactive pleural thickening and non-epithelioid mesothelioma is a considerable challenge for pathologists and one of the most common reasons for diagnostic ...

For example, pleural mesothelioma patients with BAP1 germline mutations who receive platinum-based chemotherapy live significantly longer, 7.9 years compared to 2.4 years for those without these ...

The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

The FDA on Wednesday approved a new indication for Merck ’s blockbuster cancer therapy Keytruda (pembrolizumab), adding pleural mesothelioma to the already-extensive list of malignancies that the PD-1 ...